Challenges in circulating miRNA analysis in adrenocortical tumors

Area of Science:

• Endocrinology
• Molecular Biology
• Biomarker Discovery

Background:

• Adrenocortical tumors require accurate differentiation between benign and malignant types.
• Circulating microRNAs (miRNAs) show potential as biomarkers for adrenocortical cancer (ACC).
• Technical and biological standardization challenges hinder miRNA biomarker utility.

Purpose of the Study:

• To evaluate the interchangeability of quantitative polymerase chain reaction (qPCR) and digital PCR (dPCR) for circulating miRNA measurement.
• To investigate the influence of K2-EDTA and K3-EDTA anticoagulants on miRNA quantification.
• To assess method-specific biases and anticoagulant effects on miRNA biomarker accuracy.

Main Methods:

• Simultaneous blood collection from 20 participants into K2-EDTA and K3-EDTA tubes.
• Analysis of three ACC-associated miRNAs (miR-483-5p, miR-210-3p, miR-21-5p) and two controls (miR-16-5p, cel-miR-39-3p).
• Measurement using both RT-qPCR and dPCR techniques.

Main Results:

• qPCR and dPCR yielded different correlations, with K2-EDTA showing better performance in ΔCt values.
• Proportional biases were observed between methods, particularly for low or high miRNA expressions.
• K3-EDTA influenced qPCR measurements, increasing standard deviations, while dPCR results were unaffected by anticoagulant choice.

Conclusions:

• dPCR and qPCR are not readily interchangeable for circulating miRNA analysis, impacting cross-validation studies.
• Anticoagulant choice (K2- vs. K3-EDTA) can affect qPCR outcomes, necessitating standardized protocols.
• A consensus methodology is essential to improve reproducibility and enhance miRNA biomarker utility in adrenocortical tumor diagnostics.